Fall 2015 Week 4

Question 1

Metformin (Class)

Answer 1

Diabetes - Biguanides

Question 2

Metformin (Dosage and Indication)

Answer 2

Orally IR Two to Three Times Daily
Extended Release Once Daily
(po qd, bid or tid)

Type 2 Diabetes Mellitus

Question 3

Metformin (Brand Names)

Answer 3

Glucophage

Question 4

Metformin (Adverse Effects)

Answer 4

Diarrhea, Nausea/Vomiting, Flatulence, Asthenia, Dyspepsia, Hypoglycemia

Question 5

Glyburide (Class)

Answer 5

Diabetes - Sulfonylureas

Question 6

Glyburide (Dosage and Indication)

Answer 6

Oral Once or Twice Daily
(po qd)
Type 2 Diabetes Mellitus

Question 7

Glyburide (Brand Names)

Answer 7

Diabeta, Micronase

Question 8

Glyburide (Adverse Effects)

Answer 8

Cutaneous hypersensitivity, Blurred Vision, Heartburn,, Nausea, Hypoglycemia

Question 9

Glipizide (Class)

Answer 9

Sulfonylureas

Question 10

Glipizide (Dosage and Indication)

Answer 10

IR Oral Once or Twice Daily
ER Oral Once Daily
(po qd or bid)
Type 2 Diabetes Mellitus

Question 11

Glipizide (Brand Names)

Answer 11

Glucotrol

Question 12

Glipizide (Adverse Effects)

Answer 12

Cutaneous Hypersensitivity, Diarrhea, Nausea, Headache, Tremors, Nervousness

Question 13

Rosiglitazone (Class)

Answer 13

Thiazolidinediones

Question 14

Rosiglitazone (Dosage and Indications)

Answer 14

Oral Once or Twice Daily
(po qd or bid)
Type 2 Diabetes Mellitus

Question 15

Pioglitazone (Class)

Answer 15

Thiazolidinediones

Question 16

Pioglitazone (Dosage and Indication)

Answer 16

Oral Once Daily
(po qd)
Type 2 Diabetes Mellitus

Question 17

Rosiglitazone (Brand Names)

Answer 17

Avandia

Question 18

Rosiglitazone (Adverse Effects)

Answer 18

Upper Respiratory Tract Infections, Edema

Question 19

Pioglitazone (Brand Names)

Answer 19

Actos

Question 20

Pioglitazone (Adverse Effects)

Answer 20

Myalgia, Pharyngitis, Sinusitis, Upper Respiratory Tract Infections, Flatulence

Question 21

Sitagliptin (Class)

Answer 21

DPP-4 Inhibitors

Question 22

Sitagliptin (Dosage and Indications)

Answer 22

Oral Once Daily
(po qd)
Type 1 Diabetes Mellitus

Question 23

Sitagliptin (Brand Names)

Answer 23

Januvia

Question 24

Sitagliptin (Adverse Effects)

Answer 24

Nasopharyngitis, Upper Respiratory Tract Infection

Question 25

Regular Insulin (Class)

Answer 25

Insulin

Question 26

Regular (Dosage and Indications)

Answer 26

Two or more subcutaneous doses daily | (sc bid, tid or qd) Type 1 and 2 Diabetes Mellitus

Question 27

Regular (Brand Names)

Answer 27

Humulin R, Novolin R

Question 28

Regular (Adverse Effects)

Answer 28

Lipodystrophy, Erythema/Irritation at Injection Site, Hypoglycemia, Pruritus, Peripheral Edema

Question 29

NPH (Class)

Answer 29

Insulin

Question 30

NPH (Brand Names)

Answer 30

Humulin N, Novolin N

Question 31

NPH (Dosage and Indications)

Answer 31

Once or Twice Subcutaneously Daily (sc qd or subq bid) Type 1 and 2 Diabetes Mellitus

Question 32

NPH (Adverse Effects)

Answer 32

Lipodystrophy, erythema/irritation at injection site, Hypoglycemia, Pruritus, Peripheral Edema

Question 33

Lispro (Class)

Answer 33

Insulin

Question 34

Lispro (Dosage and Indications)

Answer 34

Once or twice daily for intermediate and long acting insulin (sc qd or bid) Type 1 or 2 Diabetes Mellitus

Question 35

Lispro (Adverse Effects)

Answer 35

Hypoglycemia, Lipodystrophy, Rash, Pruritus, Injection Site Reactions, Peripheral Edema

Question 36

Aspart (Class)

Answer 36

Insulin

Question 37

Aspart (Dosage and Indications)

Answer 37

Once or twice daily for intermediate and long acting insulin (sc qd or bid) Rapid Acting Three or more times daily (sc tid+) Type 1 and 2 Diabetes Mellitus

Question 38

Lispro (Brand Names)

Answer 38

Humalog

Question 39

Aspart (Brand Names)

Answer 39

Novolog

Question 40

Aspart (Adverse Effects)

Answer 40

Hyporeflexia/Sensory Disturbance, Onychomycosis, UTI, Injection site irritation, Lipodystrophy, Weight Gain

Question 41

Glargine (Class)

Answer 41

Insulin

Question 42

Glargine (Dosage and Indications)

Answer 42

Once or twice daily for intermediate and long acting insulin (sc qd or bid) Rapid Acting Three or more times daily (sc tid+) Type 1 and 2 Diabetes Mellitus

Question 43

Glargine (Brand Names)

Answer 43

Lantus

Question 44

Glargine (Adverse Effects)

Answer 44

Injection Site Irritation, Lipodystrophy, Pruritus, Rash, Edema, Weight Gain, Hypoglycemia

Question 45

Detemir (Class)

Answer 45

Insulin

Question 46

Detemir (Dosage and Indications)

Answer 46

Subcutaneously once or twice daily (subq qd or bid) Type 1 or 2 Diabetes Mellitus

Question 47

Detemir (Brand Names)

Answer 47

Levemir

Question 48

Detemir (Adverse Effects)

Answer 48

Lipodystrophy, Allergic Reactions, Severe Hypoglycemia